SCHEMBL12295658

SCHEMBL12295658

Cc1ccc(-c2nc(C3COC4(CCN(C(=O)Nc5nnnn5C)CC4)C3)no2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.40
TSHR P16473 3/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
GAA P10253 1/20 0.37
USP7 Q93009 1/20 0.36
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TUBB4A P04350 1/20 0.34
TUBB P07437 1/20 0.34
TUBA3C P0DPH7 1/20 0.34
TUBA1B P68363 1/20 0.34
TUBA4A P68366 1/20 0.34
TUBB4B P68371 1/20 0.34
TUBB3 Q13509 1/20 0.34
TUBB2A Q13885 1/20 0.34
TUBB8 Q3ZCM7 1/20 0.34
TUBA3E Q6PEY2 1/20 0.34
TUBA1A Q71U36 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2424231 0.91 KMT2A (0.43) TSHRLMNAKDM4EMEN1KMT2A
SCHEMBL2427483 0.89 EPHX2 (0.41) TRPM8
SCHEMBL12295693 0.83 MGLL (0.39) POLBKDM4ETUBB4ATUBBTUBA3C
SCHEMBL12295624 0.83 HTT (0.41) HTTTSHRLMNAPOLBGAA
SCHEMBL12295646 0.80 MGLL (0.41) POLBALDH1A1TRPM8MAPTMAPK1
SCHEMBL2339492 0.79 KMT2A (0.45) HTTTSHRLMNAUSP7KDM4E
SCHEMBL2340806 0.77 EPHX2 (0.43) TRPM8
SCHEMBL12295692 0.77 MGLL (0.36) TRPM8MAPT
SCHEMBL2425964 0.76 MGLL (0.41) HTTPOLBMEN1KMT2AALDH1A1
SCHEMBL2427364 0.76 MGLL (0.40) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110230493-A1 1-OXA-8-Azaspiro [4,5] Decabe-8-Carboxamide Compounds as FAAH Inhibitors PFIZER INC. 2011-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230493-A1 1-OXA-8-Azaspiro [4,5] Decabe-8-Carboxamide Compounds as FAAH Inhibitors FAAH, FAAH2, FFAR1 HTT 3215/4885TSHR 1261/4885LMNA 3357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.